IP Library › Granted Patent US 11,421,213
Granted Patent B2
US 11,421,213 · App. 16/644,191 · Granted Aug 23, 2022

Performance-enhanced protease variants II

Inventors: Layla Fernandez (Cologne, DE); Sabine Griemert (Monheim am Rhein, DE); Nina Mussmann (Willich, DE); Susanne Wieland (Dormagen/Zons, DE); Daniela Herbst (Duesseldorf, DE); Inken Prueser (Duesseldorf, DE); Christian Degering (Erkrath, DE); Daria Strauss (Duesseldorf, DE); Thorsten Eggert (Hattingen, DE); Christian Leggewie (Muelheim an der Ruhr, DE)
Assignee: HENKEL AG & CO. KGAA
C12N9/54C11D3/386C12Y304/21062
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,421,213
App. No.
16/644,191
Granted
Aug 23, 2022
Kind
B2
Abstract

An amino acid sequence may have at least 70% sequence identity to the amino acid sequence identified in SEQ ID No. 1 over its entire length, and (a) amino acid substitutions at the positions corresponding to the positions 9 and 271 in each case based on the numbering according to SEQ ID No. 1, and (b) an amino acid substitution on at least one of the positions corresponding to the positions 29, 48, 101, 30, 131, 133, 144, 224 or 252, in each case based on the numbering according to SEQ ID No. 1. Such proteases are particularly suitable for having an improved cleaning performance.

Claims (67)

1. A protease comprising an amino acid sequence having at least 85% sequence identity with the amino acid sequence given in SEQ ID NO:1 over its entire length and having, in each case based on the numbering according to SEQ ID NO:1, amino acid substitutions which occur:

(a) at the positions corresponding to positions 9 and 271, and

(b) at one or more positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 224, and 252, in each case based on the numbering according to SEQ ID NO:1.

2. The protease according to claim 1 , wherein:

(1) the amino acid substitution at the position 9 is the amino acid substitution 9T, 9H, 9S, or 9A; and wherein the amino acid substitution at the position 271 is Q271E;

(2) the one or more amino acid substitutions according to (b) is selected from the group consisting of A29G, A48V, D101E, N130D, N1305, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y,N144K,N144L,N144A, S224A, S224T, and N252S, in each case based on the numbering according to SEQ ID NO:1; or

(3) both.

3. The protease according to claim 1 , wherein amino acid substitutions occur:

(1) at the positions corresponding to positions 9 and 271 and one or more of 130, 131, 133, 144, and 224 in each case based on the numbering according to SEQ ID NO:1, and

(2) optionally at one or more of the positions corresponding to positions 29, 48, 101, and 252 in each case based on the numbering according to SEQ ID NO:1.

4. The protease according to claim 1 , wherein the amino acid substitutions, in each case based on the numbering according to SEQ ID NO:1: occur at P9T, P9H, P9S, or P9A, corresponding to position 9 and Q271E corresponding to position 271, optionally S216C corresponding to position 216, as well as additional amino acid substitutions according to one or more of the following:

(i) N130D, G131S, T133Y, and 5224A;

(ii) N1305, G131S, T133Y, N144L, and 5224A;

(iii) N130D, G131N, T133K, and N144K;

(iv) N130H, G131N, N144K, and 5224A;

(v) A29G, N130D, G131N, and T133R;

(vi) A29G, D101E, N1305, G131S, S224T, and N252S;

(vii) N130H, G131S, and 5224A;

(viii) N130D, G131S, T133K, and 5224A;

(ix) A29G, D101E, N130D, G131K, and 5224A;

(x) N130D, G131N, T133K, N144L, and N252S;

(xi) G131S, N144K ,and S224T;

(xii) D101E, N130D, G131S, T133Y, N144A, and 5224A;

(xiii) A29G, D101E, N1305, S224T, and N252S;

(xiv) A48V, G131S, T133R, and 5224A; and

(xv) G131D, T133R, and S224A.

5. The protease according to claim 1 , wherein the amino acid substitutions occur, based on the numbering according to SEQ ID NO:1:

at a further position corresponding to 166 as 166M, 166Q, or 166A; at one or more additional positions corresponding to positions 62, 133, 149, 156, 172, and 217; or both.

6. The protease according to claim 5 , wherein the amino acid substitutions at the one or more additional positions corresponding to positions 62, 133, 149, 156, 172, and 217 are selected from the amino acid substitutions 62S, 133R, 133A, 133K, 1491, 156G, 156Q, 172P, 172G, and 217M.

7. The protease according to claim 1 , wherein the protease has an amino acid sequence according to one of SEQ ID Nos. 3-17 or 19-23.

8. A protease according to claim 1 , further comprising a single or multiple conservative amino acid substitution, wherein the protease comprises:

(i) the amino acid substitutions P9T, P9H, P9S, or P9A corresponding to position 9 and Q271E corresponding to position 271 based on the numbering according to SEQ ID NO:1, and

(ii) one or more of the amino acid substitutions A29G, A48V, D101E, N130D, N1305, N130H, G131S, G131N, G131D, G131K, T133K, T133R, T133Y, N144K, N144L, N144A, S224A, S224T, and N252S at the positions corresponding to positions 29, 48, 101, 130, 131, 133, 144, 224, and 252 based on the numbering according to SEQ ID NO:1.

9. A composition comprising:

at least one protease according to claim 1 and a washing or cleaning agent; and

one or more surfactants.

10. The composition of claim 9 , wherein the protease comprises:

(1) the amino acid substitution at the position 9 is the amino acid substitution 9T, 9H, 9S, or 9A; and wherein the amino acid substitution at the position 271 is Q271E;

(2) the one or more amino acid substitutions according to (b) is selected from the group consisting of A29G, A48V, D101E, N130D, N130S, N130H, G131D, G131N, G131S, G131K, T133K, T133R, T133Y, N144K,N144L,N144A, S224A, S224T, and N252S, in each case based on the numbering according to SEQ ID NO:1;

(3) or both.

11. The composition of claim 9 , wherein the protease comprises the following amino acid substitutions:

(1) at the positions corresponding to positions 9 and 271 and one or more of 130, 131, 133, 144, and 224 in each case based on the numbering according to SEQ ID NO:1, and

(2) optionally at one or more of the positions corresponding to positions 29, 48, 101, and 252 in each case based on the numbering according to SEQ ID NO:1.

12. The composition of claim 9 , wherein the protease comprises the following amino acid substitutions, in each case based on the numbering according to SEQ ID NO: 1 , which occur at P9T, P9H, P9S, or P9A, corresponding to position 9 and Q271E corresponding to position 271, optionally S216C corresponding to position 216, as well as additional amino acid substitutions according to one or more of the following:

(i) N130D, G131S, T133Y, and S224A;

(ii) N1305, G131S, T133Y, N144L, and S224A;

(iii) N130D, G131N, T133K, and N144K;

(iv) N130H, G131N, N144K, and S224A;

(v) A29G, N130D, G131N, and T133R;

(vi) A29G, D101E, N130S, G131S, S224T, and N252S;

(vii) N130H, G131S, and S224A;

(viii) N130D, G131S, T133K, and S224A;

(ix) A29G, D101E, N130D, G131K, and S224A;

(x) N130D, G131N, T133K, N144L, and N252S;

(xi) G131S, N144K ,and S224T;

(xii) D101E, N130D, G131S, T133Y, N144A, and S224A;

(xiii) A29G, D101E, N130S, S224T, and N252S;

(xiv) A48V, G131S, T133R, and S224A; and

(xv) G131D, T133R, and S224A.

13. The composition of claim 9 , wherein the amino acid substitutions occur, based on the number according to SEQ ID NO:1:

(b1) at the position corresponding to 166 as 166M, 166Q, or 166A;

(b2) at one or more of the positions corresponding to positions 62, 133, 149, 156, 172, and 217;

(b3) or both.

14. The protease according to claim 1 , wherein the protease comprises amino acid substitutions at the positions corresponding to positions 9 and 271, and at one or more of the positions corresponding to positions 29, 48, 131, 133, 144, 224, and 252 in each case based on the numbering according to SEQ ID NO:1.

15. A protease comprising an amino acid sequence having at least 85% sequence identity with the amino acid sequence given in SEQ ID NO:1 over its entire length and having, in each case based on the numbering according to SEQ ID NO:1 amino acid substitutions which occur:

(a) at the positions corresponding to positions 9, 130, 144, 252, and 271 as the amino acid substitutions 9T, 130D, 144K, 252T, and 271E, and

(b) optionally at one or more additional positions corresponding to positions 62, 133, 149, 156, 166, 172, and 217 as amino acid substitutions 62S, 133R, 133A, 133K, 1491, 156G, 156Q, 166M, 166Q, 166A, 172P, 172G, and 217M.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2020
From: FERNANDEZ, LAYLA; GRIEMERT, SABINE; MUSSMANN, NINA; WIELAND, SUSANNE; HERBST, DANIELA; PRUESER, INKEN; DEGERING, CHRISTIAN; STRAUSS, DARIA; EGGERT, THORSTEN; LEGGEWIE, CHRISTIAN
To: HENKEL AG & CO. KGAA
Reel/Frame 052092/0427 →
Priority Claims (2)
DE 10 2017 215 631.7 · Sep 5, 2017 · national
DE 10 2018 208 777.6 · Jun 5, 2018 · national
Continuity (1)
Related Publication 20200231957A1 · Jul 23, 2020
Cited By (1)
US 12,398,386